Basic Information
TASCENSO ODT
70709-062
Regulatory Information
70709-062
NDA214962
C73594
January 24, 2023
USA
These highlights do not include all the information needed to use TASCENSO ODT™ safely and effectively. See full prescribing information for TASCENSO ODT. TASCENSO ODT (fingolimod) orally disintegrating tablets Initial U.S. Approval: 2010
HUMAN PRESCRIPTION DRUG LABEL
3
Company Information
218215530
Active Ingredients
GELATIN, UNSPECIFIED
Code: 2G86QN327L
Class Code: IACT
MEDIUM-CHAIN TRIGLYCERIDES
Code: C9H2L21V7U
Class Code: IACT
Sodium Chloride
Code: 451W47IQ8X
Class Code: IACT
MANNITOL
Code: 3OWL53L36A
Class Code: IACT
SODIUM LAURYL SULFATE
Code: 368GB5141J
Class Code: IACT
Active Moieties
Fingolimod
Code: 3QN8BYN5QF